Medical News

RSS

Nucleic Acid Therapeutics publishes special research section on noncoding RNAs

As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention. Guest Editor Tom Cech, PhD and Executive Editor Fintan Steele, PhD explore the enormous potential value of this rapidly advancing research area in their Editorial " The (Noncoding) RNA World."

15 Feb 2013

Castle Biosciences launches MyUvealMelanoma website

Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.

15 Feb 2013

SPI Pharma launches Actimask Ibuprofen 92S

SPI Pharma, Inc., a global leader in providing pharmaceutical ingredients and technologies for patient-friendly dosage forms, announces the launch of Actimask Ibuprofen 92S, a taste-masked Ibuprofen.

15 Feb 2013

AccentHealth purchases Everwell waiting room television network

AccentHealth, the nation's largest media network at the Point-of-Care, announced today it has purchased the Everwell waiting room television network, a division of MediVista Media, LLC.

15 Feb 2013

ASGCT to honor UNC genetics professor with 2013 Outstanding New Investigator Award

Aravind Asokan, PhD, assistant professor of genetics in the University of North Carolina School of Medicine, was selected by the American Society of Gene and Cell Therapy to receive a 2013 Outstanding New Investigator Award.

15 Feb 2013

ADAMTS7 enzyme plays a crucial role in coronary heart disease

Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.

15 Feb 2013

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

In 2012, The Myeloproliferative Neoplasm (MPN) Research Foundation and The Leukemia & Lymphoma Society (LLS) jointly issued the MF Challenge Grant , seeking innovative approaches to reversing fibrosis in patients with myelofibrosis (MF).

15 Feb 2013

Viewpoints: FDA needs more power to regulate compounding pharmacies; Time to revamp military benefits, including health

Traditionally, the licensing and control of pharmacies has been left to the states, but their performance has been uneven. The federal role has been thrown into question in recent years by lawsuits. ... compounding pharmacies are not generally required to inform the FDA that they are in business nor to register with the FDA or disclose what products they are making.

15 Feb 2013

Cambrex, Dow partner to manufacture HPMCAS for drug solubility enhancement

Cambrex and The Dow Chemical Company have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility Enhancement.

15 Feb 2013

EMAS publishes clinical guide on lichen sclerosus in Maturitas journal

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society (EMAS) in its journal Maturitas on lichen sclerosus with summary recommendations.

15 Feb 2013

Masimo's total fourth quarter revenue increases 18% to $132.2 million

Masimo today announced its financial results for the fourth quarter and year ended December 29, 2012.

15 Feb 2013

Ingenuity Systems receives HIPAA Certification

Ingenuity Systems, a leading provider of biomedical information and analysis solutions, today announced that it has passed the Health Insurance Portability and Accountability Act (HIPAA) audit, confirming that Ingenuity's data center and Ingenuity Variant Analysis are in compliance with relevant Federal Regulations.

15 Feb 2013

Exposure to two common PFCs associated with increased risk of osteoarthritis

A new study has linked exposure to two common perfluorinated chemicals (PFCs) with osteoarthritis. PFCs are used in more than 200 industrial processes and consumer products including certain stain- and water-resistant fabrics, grease-proof paper food containers, personal care products, and other items.

15 Feb 2013

Mallinckrodt, Actavis enter settlement agreement to resolve Exalgo patent litigation

Actavis, Inc. today announced that it has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Actavis' generic version of the 32 mg dosage strength of Mallinckrodt's Exalgo (Hydromorphone Hydrochloride Extended-Release) tablets.

15 Feb 2013

National Mentor Holdings first quarter revenues increase 7.5% to $294.9 million

National Mentor Holdings, Inc. today announced its financial results for the first quarter ended December 31, 2012.

15 Feb 2013

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Gamida Cell announced today the successful results of the Phase I/II study of its second pipeline product NiCord, umbilical cord derived stem cells expanded using the company's proprietary NAM technology.

15 Feb 2013

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

Abortion opponents have found a new way to restrict access to abortion -- by using the authority states have over the new health insurance exchanges, which will be up and running in a year. At least 21 states have legislation in place or in the works that will stop health insurance companies from paying for abortions for women.

15 Feb 2013

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.

15 Feb 2013

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

QPID Inc. launched today, delivering a new health record intelligence platform and web-based applications that enable health care institutions and clinicians to gain better insights from any Electronic Health Record (EHR).

15 Feb 2013

Researchers solve complete 3-D structure of E6 proteins in HPV 16

For the first time, researchers from the Laboratoire biotechnologie et signalisation cellulaire at the Strasbourg-based Ecole supérieure de biotechnologie (CNRS/Université de Strasbourg) and Institut de génétique et de biologie moléculaire et cellulaire (CNRS/Université de Strasbourg/Inserm) have solved the three-dimensional structure of an important oncoprotein involved in cell proliferation and in the development of the human papilloma virus (HPV).

14 Feb 2013

Medical News

Nucleic Acid Therapeutics publishes special research section on noncoding RNAs

Castle Biosciences launches MyUvealMelanoma website

SPI Pharma launches Actimask Ibuprofen 92S

AccentHealth purchases Everwell waiting room television network

ASGCT to honor UNC genetics professor with 2013 Outstanding New Investigator Award

ADAMTS7 enzyme plays a crucial role in coronary heart disease

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

Viewpoints: FDA needs more power to regulate compounding pharmacies; Time to revamp military benefits, including health

Cambrex, Dow partner to manufacture HPMCAS for drug solubility enhancement

EMAS publishes clinical guide on lichen sclerosus in Maturitas journal

Masimo's total fourth quarter revenue increases 18% to $132.2 million

Ingenuity Systems receives HIPAA Certification

Exposure to two common PFCs associated with increased risk of osteoarthritis

Mallinckrodt, Actavis enter settlement agreement to resolve Exalgo patent litigation

National Mentor Holdings first quarter revenues increase 7.5% to $294.9 million

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

Researchers solve complete 3-D structure of E6 proteins in HPV 16

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News